1. Home
  2. PHAT vs PBFS Comparison

PHAT vs PBFS Comparison

Compare PHAT & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • PBFS
  • Stock Information
  • Founded
  • PHAT 2018
  • PBFS 1889
  • Country
  • PHAT United States
  • PBFS United States
  • Employees
  • PHAT N/A
  • PBFS N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • PBFS Banks
  • Sector
  • PHAT Health Care
  • PBFS Finance
  • Exchange
  • PHAT Nasdaq
  • PBFS Nasdaq
  • Market Cap
  • PHAT 339.8M
  • PBFS 278.5M
  • IPO Year
  • PHAT 2019
  • PBFS N/A
  • Fundamental
  • Price
  • PHAT $3.96
  • PBFS $11.27
  • Analyst Decision
  • PHAT Strong Buy
  • PBFS
  • Analyst Count
  • PHAT 5
  • PBFS 0
  • Target Price
  • PHAT $22.50
  • PBFS N/A
  • AVG Volume (30 Days)
  • PHAT 1.2M
  • PBFS 13.4K
  • Earning Date
  • PHAT 05-08-2025
  • PBFS 05-12-2025
  • Dividend Yield
  • PHAT N/A
  • PBFS N/A
  • EPS Growth
  • PHAT N/A
  • PBFS 11.77
  • EPS
  • PHAT N/A
  • PBFS 0.76
  • Revenue
  • PHAT $55,252,000.00
  • PBFS $88,118,000.00
  • Revenue This Year
  • PHAT $202.23
  • PBFS N/A
  • Revenue Next Year
  • PHAT $113.81
  • PBFS N/A
  • P/E Ratio
  • PHAT N/A
  • PBFS $14.55
  • Revenue Growth
  • PHAT 8001.47
  • PBFS 21.67
  • 52 Week Low
  • PHAT $3.81
  • PBFS $8.76
  • 52 Week High
  • PHAT $19.71
  • PBFS $12.20
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 37.83
  • PBFS 46.15
  • Support Level
  • PHAT $3.87
  • PBFS $10.60
  • Resistance Level
  • PHAT $5.09
  • PBFS $11.46
  • Average True Range (ATR)
  • PHAT 0.59
  • PBFS 0.43
  • MACD
  • PHAT -0.10
  • PBFS 0.01
  • Stochastic Oscillator
  • PHAT 6.12
  • PBFS 49.82

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

Share on Social Networks: